Glutathione Transferase Omega-1 Regulates NLRP3 Inflammasome Activation through NEK7 Deglutathionylation.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
01 10 2019
Historique:
received: 20 09 2018
revised: 31 07 2019
accepted: 23 08 2019
entrez: 3 10 2019
pubmed: 3 10 2019
medline: 18 9 2020
Statut: ppublish

Résumé

The NLRP3 inflammasome is a cytosolic complex sensing phagocytosed material and various damage-associated molecular patterns, triggering production of the pro-inflammatory cytokines interleukin-1 beta (IL)-1β and IL-18 and promoting pyroptosis. Here, we characterize glutathione transferase omega 1-1 (GSTO1-1), a constitutive deglutathionylating enzyme, as a regulator of the NLRP3 inflammasome. Using a small molecule inhibitor of GSTO1-1 termed C1-27, endogenous GSTO1-1 knockdown, and GSTO1-1

Identifiants

pubmed: 31577945
pii: S2211-1247(19)31127-1
doi: 10.1016/j.celrep.2019.08.072
pii:
doi:

Substances chimiques

Cytokines 0
Inflammasomes 0
Inflammation Mediators 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
NLRP3 protein, human 0
GSTO1 protein, human EC 2.5.1.18
Glutathione Transferase EC 2.5.1.18
NEK7 protein, human EC 2.7.11.1
NIMA-Related Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-161.e5

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Mark M Hughes (MM)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland; Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.

Alexander Hooftman (A)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Stefano Angiari (S)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Padmaja Tummala (P)

John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.

Zbigniew Zaslona (Z)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Marah C Runtsch (MC)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Anne F McGettrick (AF)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Caroline E Sutton (CE)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Ciana Diskin (C)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Melissa Rooke (M)

John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.

Shuhei Takahashi (S)

Department of Human Pathology, Graduate School and Faculty of Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.

Srinivasan Sundararaj (S)

John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.

Marco G Casarotto (MG)

John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.

Jane E Dahlstrom (JE)

ACT Pathology and ANU Medical School, The Canberra Hospital, Canberra, ACT, Australia.

Eva M Palsson-McDermott (EM)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Sinead C Corr (SC)

Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, Dublin 2, Ireland.

Kingston H G Mills (KHG)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.

Roger J S Preston (RJS)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland.

Nouri Neamati (N)

Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90033, USA; Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, 2800 Plymouth Road, Building 520, Room 1363, Ann Arbor, MI 48109, USA; Translational Oncology Program, University of Michigan, 2800 Plymouth Road, Building 520, Room 1363, Ann Arbor, MI 48109, USA.

Yiyue Xie (Y)

Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.

Jonathan B Baell (JB)

Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia.

Philip G Board (PG)

John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia.

Luke A J O'Neill (LAJ)

School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. Electronic address: laoneill@tcd.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH